CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) Posted Basic Consolidated EPS Of $-3.0523

0

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) annual basic consolidated EPS was $-3.0523 for the period ended 2015-12-31. The basic consolidated EPS was $-3.0523 for the quarter ended 2015-12-31.

EPS from continuing operations

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD)’s basic EPS from continuing operations was $-3.0523 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-3.0523

EPS contribution from parent

From the parent company CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) posted basic EPS of $-3.0523 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-3.0523.

Basic net EPS

The Basic net EPS of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) was $-3.82 for the period ended 2015-12-31. The figure stood at $-3.82 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-3.0523. While the figure for the quarter ended 2015-12-31 stood at $-3.0523.

Basic diluted EPS

The diluted EPS from continuing operation of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) stood at $-3.0523 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-3.0523

Net diluted EPS

The Net diluted EPS was $-3.82 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-3.82.

Diluted EPS from parent

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) diluted EPS from the parent company for the fiscal 2015-12-31 was $-3.0523. The figure for the quarter ended 2015-12-31 was $-3.0523

The net basic EPS was $-3.82 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-3.82.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 3 times, 1 visits today)